{"url_path":"/sec/rkda/8-k/2026-05-14/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1469443/0001193125-26-223985-index.html","accession_number":"0001193125-26-223985","cik":"0001469443","ticker":"RKDA","issuer_name":"Arcadia Biosciences, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1469443/0001193125-26-223985-index.html","primary_entity_key":"0001469443","primary_entity_name":"Arcadia Biosciences, Inc."},"word_count":90,"has_tables":true,"body_markdown":"## Item 9.01 Financial Statements and Exhibits.\n\n## (d) Exhibits\n\nExhibit No.\n\nDescription\n\n99.1\n\n[Arcadia Biosciences Announces First-Quarter 2026 Financial Results and Business Highlights](rkda-ex99_1.htm)\n\n99.2\n\n[Arcadia Biosciences First-Quarter 2026 Financial Information](rkda-ex99_2.htm)\n\n104\n\nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.\n\n \n\n \n\n \n\nARCADIA BIOSCIENCES, INC.\n\n \n\n \n\n \n\n \n\nDate:\n\nMay 14, 2026\n\nBy:\n\n/s/ THOMAS J. SCHAEFER\n\n \n\n \n\n \n\nThomas J. Schaefer, Chief Executive Officer"}